Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Analysis finds that after 2 years GLP-1 drugs for weight loss don’t justify their price
Study of those who started taking blockbuster weight loss drugs in 2021 suggests patients need support services, not just the medications.
Weight-loss surgeries decline 25% as GLP-1 drugs grow in popularity
As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds.
In the era of GLP-1 drugs, demand for bariatric surgery plunges
The findings spell an uncertain future for hospitals and clinics that derive a significant portion of their revenues from obesity procedures.
New York City Utterly Screwed Up Insurance for Employees Taking GLP-1 Weight Loss Drugs
After insurance for New York City employees began covering GLP-1 weight-loss injectables, more than 1,000 city workers and their dependents began using the drugs — and now, they're being told that coverage was accidental.
Study: GLP-1 weight-loss drugs might lower, not increase, teen suicide risk
In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and suicide attempts compared to adolescents who didn't.
Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 Meds
Prescriptions of this GLP-1 class of diabetes and weight-loss medications more than doubled between 2022 and 2023, a new tally finds. "In contrast, there was a 25.6% decrease in patients undergoing metabolic bariatric surgery" during the same time period,
The Truth About Weight Loss Drugs
Meds like Wegovy are all over the news. But are they right for you, especially if you're older than the average user?By Hallie LevineAre you wondering whether you’re a candidate for one of the
12h
Ars Live: Join us Tuesday as we discuss GLP-1 drugs—insights and unknowns
News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to ...
2d
on MSN
Do 'Natural GLP-1 Supplements' Actually Work? Here's What Experts Think.
Food naturally boosts your body’s GLP-1 levels, explained Dr. Sun Kim, an endocrinologist at Stanford Health Care in ...
Medpage Today on MSN
1d
GLP-1 Drugs Tied to Reduced Risk of Uterine Fibroids
Among patients who took at least two doses of medication, GLP-1 receptor agonists were associated with a significantly lower ...
Peninsula Daily News
6h
GlucoBoost GLP-1 Booster: Reviewing The Natural Weight Loss Secret Doctors Won’t Tell You About
In a world increasingly focused on health and wellness, finding effective solutions for weight management can be challenging.
STAT
2d
More state Medicaid programs consider covering GLP-1 drugs
While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...
EatingWell on MSN
5d
What Are GLP-1 Medications & Who Should Use Them? Here's What Experts Say
There are several types of GLP-1 medications available, each with varying dosing schedules and forms of administration. Some ...
Medscape
1d
Rise in GLP-1 RA and SGLT2 Inhibitor Prescribing in Patients With T1D
An analysis of over 400,000 patients with T1D revealed a rise in prescribing for glucagon-like peptide 1 receptor agonists and sodium-glucose cotransporter 2 inhibitors over the past decade.
BioSpace
1d
GLP-1 Prescriptions for Type 1 Diabetes Spike Despite Lack of FDA Approval: Study
While the regulator has not approved their use in type 1 diabetes, off-label prescribing for GLP-1 receptor agonists has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Food and Drug Administration
Novo Nordisk
Noom
Ozempic
Wegovy
Feedback